S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
His system isolated NVIDIA - Here's His Next Buy. (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
OTCMKTS:HYBT

Heyu Biological Technology (HYBT) Stock Forecast, Price & News

$0.50
-0.04 (-7.41%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.50
$0.50
50-Day Range
$0.20
$2.90
52-Week Range
$0.00
$3.40
Volume
3,328 shs
Average Volume
331 shs
Market Capitalization
$51.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HYBT stock logo

About Heyu Biological Technology (OTCMKTS:HYBT) Stock

Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. The company is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.

HYBT Price History

HYBT Stock News Headlines

Heyu Biological Technology Corporation (HYBT)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Chongqing Zhifei Biological Products
Massachusetts Institute of Technology
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Shanghai Haohai Biological Technology Co Ltd
Heyu Biological Technology Corp
Innovita Biological Technology Co (688253)
Heyu Biological Technology Corp (HYBT)
Heyu Biological Technology Corp.
Pacific WebWorks Inc (HYBT)
See More Headlines
Receive HYBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heyu Biological Technology and its competitors with MarketBeat's FREE daily newsletter.

HYBT Company Calendar

Today
9/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:HYBT
Employees
6
Year Founded
N/A

Profitability

Net Income
$-270,000.00
Pretax Margin
-921.22%

Debt

Sales & Book Value

Annual Sales
$80,000.00
Book Value
($0.02) per share

Miscellaneous

Free Float
11,109,000
Market Cap
$51.63 million
Optionable
Not Optionable
Beta
-17.56
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Ms. Wei Li (Age 36)
    Chief Financial Officer
  • Mr. Zengqiang Lin (Age 27)
    Pres, CEO & Director













HYBT Stock - Frequently Asked Questions

How have HYBT shares performed in 2023?

Heyu Biological Technology's stock was trading at $0.0140 at the beginning of 2023. Since then, HYBT shares have increased by 3,471.4% and is now trading at $0.50.
View the best growth stocks for 2023 here
.

When did Heyu Biological Technology's stock split?

Heyu Biological Technology's stock reverse split on Monday, August 14th 2023. The 1-10 reverse split was announced on Monday, August 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Heyu Biological Technology's stock symbol?

Heyu Biological Technology trades on the OTCMKTS under the ticker symbol "HYBT."

How do I buy shares of Heyu Biological Technology?

Shares of HYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Heyu Biological Technology's stock price today?

One share of HYBT stock can currently be purchased for approximately $0.50.

How much money does Heyu Biological Technology make?

Heyu Biological Technology (OTCMKTS:HYBT) has a market capitalization of $51.63 million and generates $80,000.00 in revenue each year.

How can I contact Heyu Biological Technology?

Heyu Biological Technology's mailing address is ROOM 1901 BAOTUO BUILDING 617 SISHUI STREET HULI DISTRICT, XIAMEN CITY FUJIAN PROVINCE F4, 361009. The official website for the company is heyubt.com. The company can be reached via phone at 8615859240902, via email at ir@pacificwebworks.com, or via fax at 858-459-1103.

This page (OTCMKTS:HYBT) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -